PEGGY: A phase II randomised study of the PI3-kinase (PI3K) inhibitor pictilisib (GDC-0941) plus paclitaxel in patients (pts) with hormone receptor...

Date 26 September 2015
Event European Cancer Congress 2015
Session Breast Cancer - Advanced Disease
Topics Breast Cancer, Metastatic
Presenter Vuylsteke, P.